DOCSLIB.ORG

Of H5N1 Virus

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Of H5N1 Virus An Intracellular Human Single Chain Antibody to Matrix Protein (M1) of H5N1 Virus He Sun Jilin Agricultural University https://orcid.org/0000-0002-8378-3789 Guangmou Wu Chinese Academy of Agricultural Sciences Changchun Veterinary Research Institute Jiyuan Zhang Changchun University Tourism College Yu Wang Jilin Agricultural University Yue Qiu Jilin Agricultural University Hongyang Man Jilin Agricultural University Guoli Zhang Chinese Academy of Agricultural Sciences Changchun Veterinary Research Institute Zehong Li Jilin Agricultural University Yuhuan Yue ( [email protected] ) Chinese Academy of Agricultural Sciences Changchun Veterinary Research Institute Yuan Tian Chinese Academy of Agricultural Sciences Changchun Veterinary Research Institute Research Keywords: H5N1, HuScFv, Phage display, Antigen-binding epitopes Posted Date: August 31st, 2021 DOI: https://doi.org/10.21203/rs.3.rs-817839/v1 License: This work is licensed under a Creative Commons Attribution 4.0 International License. Read Full License Page 1/19 Abstract Background: Inuenza virus matrix protein M1 is encoded by viral RNA fragment 7 and is the most abundant protein in virus particles. M1 is expressed in the late stages of viral replication and exerts functionality by inhibiting viral transcription. The M1 protein sequence is an attractive target for antibody drugs. Methods: The M1 protein sequence was amplied by RT-PCR using cDNA from the H5N1 virus as a template; the M1 protein was then expressed and puried. A human strain, high anity, and single chain antibody (HuScFv) against M1 protein was obtained by phage antibody library screening using M1 as an antigen. A recombinant TAT-HuScFv protein was expressed by fusion with the TAT protein transduction domain (PTD) gene of HIV to prepare a human intracellular antibody against avian inuenza virus. The differences between HuScFv and TAT-HUScFv were veried by various experiments and the amino acid binding site of the M1 protein was determined. Results: The M1 protein of H5N1, HuScFv, and TAT-HuScFv, were successfully puried and expressed by and in E. coli. Further analysis demonstrated that TAT-HuScFv inhibited the hemagglutination activity of the 300TCID50 H1N1 virus, thus providing preliminary validation of the universality of the antibody. After two rounds of M1 protein decomposition, the TAT-HuScFv antigen binding site was identied as Alanine (A) at position 239. Collectively, our data describe a recombinant antibody with high binding activity against the conserved sequences of avian inuenza viruses. This intracellular recombinant antibody blocked the M1 protein that infected intracellular viruses, thus inhibiting the replication and reproduction of H5N1 viruses. Conclusion: Recombinant HuScFv was successfully identied using the Tomlinson (I+J) phage antibody library and successfully linked to the TAT protein transductive domain of the HIV virus. Compared with the HuScFv, the addition of the TAT peptide improved its ability to penetrate the cell membrane. A denite amino acid binding site was identied after the decomposition of M1 protein, thus providing a target and reference for the development of antibody drugs and the study of new drugs. Introduction The H5N1 virus is a highly pathogenic type A avian inuenza that can cause systemic or respiratory disease in humans (Yee, Carpenter, and Cardona 2009). However, H5N1 is mainly transmitted among birds leads to death. The highly pathogenic H5N1 avian inuenza virus has infected more than 500 million poultry worldwide since human infection with the H5N1 subtype was rst reported in Hong Kong, China, in 1997 (Chen 2009). Subsequently, human infections have emerged in Asia, Europe, and Africa, consequently leading to signicant public health concerns (Joseph et al. 2017). The 16 sub-types of hemagglutinin HA (H1-H16) and the nine sub-types of neuraminidase NA (N1-N9) are proteins involved in avian inuenza (Noisumdaeng et al. 2021). The combination of different subtypes of HA and NA is responsible for the signicant diversity of avian inuenza viruses. Page 2/19 The inuenza virus matrix protein is encoded by viral RNA fragment 7; this has two open reading frames and can therefore be transcribed into two mRNAs that are translated into M1 and M2 proteins, respectively (Raman et al. 2020). The M1 protein, with molecular weight of approximately 26 kD, is found extensively in virions, and its sequence is highly conserved. Based on these characteristics, M1 has been used as the basis for classifying inuenza viruses into types A, B and C. M1 protein is expressed in the late stages of viral replication and is concentrated in discrete cell lacunae (Poungpair et al. 2009). A small amount of M1 protein translocates to the nucleus during the late stages of viral infection and helps to inhibit viral transcription. Thereafter, M1 interacts with the NEP (NS2 protein) tail encoded by viral RNA fragment 8 to export vRNP from the nucleus to the cytoplasm (Mok et al. 2017; Paterson and Fodor 2012), thus triggering the budding process and the release of virions. M1 and RNA fragments that encode M1 are the most attractive target sites for antibody drugs, gene silencing, and drug therapy (Dong-Din-On et al. 2015; Poungpair et al. 2010). In this study, a single chain antibody with high anity was screened by the application of a phage antibody library-Tomlinson I + J based on the M1 protein of the H5N1 virus as a target. In view of the transduction properties of protein transduction domain (PTD)-mediated protein across the cell membrane, the PTD of HIV was used to link to the single-chain antibody molecules (Yin et al. 2020; Shim et al. 2018; Lin and Kao 2015). Following the expression of this segment as a fusion protein with HuScFv, we observed ecient the ecient transfer of TAT-HuScFv into virus-infected cells (Zhang, Zhang, and Wang 2012; Theisen et al. 2006) and the specic binding of the intracellular M1 protein, thus preventing the assembly and release of the inuenza virus and suggesting that this antibody could be used as an antiviral drug. Materials And Methods Vectors, Bacterial Strains, Helper Phage, and Libraries The cloning and expression vector pET-Sumo, E. coli strain BL21 (DE3) and SUMO enzyme were purchased from Invitrogen Biotechnology Co. (CA, USA). The pET28a-TAT-GFP vector was constructed previously by our research group. A Tomlinson (I+J) phage antibody library, E. coli strains (TG, HB2151) and helper phage (KM13) were obtained from the Medical Research Council in Cambridge, UK. Goat anti- mouse IgG labeled horseradish peroxidase (HRP) antibody and anti-HIS6 labeled antibody were purchased from Abbot Trading Co., Ltd (Shanghai, China). The Protein A-HPR antibody was purchased from Abcam Co. (Cambridge, England). SP Sepharose 4 FF, Chelated Sepharose 4 FF, rProtein-A Sepharose 4 FF, and AKTA Prime chromatographs, were purchased from GE Healthcare (Faireld, CT, USA). Stocks of H5N1 (A/Meerkat/Shanghai/SH-1/2012) and H1N1 (A/Changchun/01/2009) viruses are held in our Institute. Expression and Purication of H5N1-M1 Protein The cDNA sequence of the M1 protein for H5N1 virus was identied in the NCBI library; this sequence was then used as a template for primer design: forward: 5′-ATG AGT CTT CTA ACC GAG GTC-3′ and reverse: 5′- Page 3/19 CCG GAA TTC TTA CTT GAA TCG CTG CAT CTG CAC T-3′. The M1 gene was amplied using H5N1 (A/Meerkat/Shanghai/SH-1/2012) cDNA as a template. The PCR reaction conditions were as follows: 94°C denaturation for 5 min, 94°C for 50 s, 50°C for 50 s, 72°C for 50 s (for 34 cycles) followed by 72°C 10 min. The amplication products were separated by gel electrophoresis and then ligated into the PET- SUMO vector with T4 ligase. The vector was sequenced and then transformed into BL21 (DE3) competent cells. Biopanning of a Phage Display Library and Selection by M1 specicity The phage antibody library was prepared in accordance with the manufacturer's instructions and then screened with the puried M1 protein as an antigen. During this process, the M1 protein was coated in 96- well plates (Nunc-Nalgene, USA) at a concentration of 5µg/ well and then incubated at 4°C overnight. The next day, the supernatant was discarded and washed three times with PBS to remove the non-adsorbed antigen. Non-specic binding was blocked with 200 µL of 2% milk/PBS at 37°C for 2 hours. After discarding the sealing solution, the wells were washed three times with PBS, and the liquid was removed by vigorous shaking. Next, the Tomlison I+J phage antibody library was added and diluted with 2% milk/PBS to a titer of 1.0 ×1013; 100 µL was added to each well, and the liquid was incubated with vigorous shaking at room temperature for 60 min. After standing for 60 min, the liquid was discarded, and the wells were washed 10 times with PBS (0.05% (V/V) Tween-20). The residual liquid in each well was patted dry and 50µL of eluting solution (5 mg/mL trypsin-PBS) was added to each well. The plates were then shaken at room temperature for 15 min to eluate the phages, which were then stored at 4°C. The eluded phage was cloned into E. coli TG1 and further panning was performed. Second, third, and fourth rounds of panning were performed under similar conditions, except that the concentration of the antigen coating was reduced to 2 µg/well. Unbound phages were removed by 20, 30, and 40 washes with PBS (0.05% (V/V) Tween-20). Next, 2% milk/PBS (100µL/Well) was added to the plate, and the plate was kept overnight at 4℃. Nonspecic binding was then blocked with 2% BSA/PBS for 2 h and the phage antibody from the fourth round of screening was added.
Load more

Recommended publications
  • Zinc and Copper Ions Differentially Regulate Prion-Like Phase
    viruses Article Zinc and Copper Ions Differentially Regulate Prion-Like Phase Separation Dynamics of Pan-Virus Nucleocapsid Biomolecular Condensates Anne Monette 1,* and Andrew J. Mouland 1,2,* 1 Lady Davis Institute at the Jewish General Hospital, Montréal, QC H3T 1E2, Canada 2 Department of Medicine, McGill University, Montréal, QC H4A 3J1, Canada * Correspondence: [email protected] (A.M.); [email protected] (A.J.M.) Received: 2 September 2020; Accepted: 12 October 2020; Published: 18 October 2020 Abstract: Liquid-liquid phase separation (LLPS) is a rapidly growing research focus due to numerous demonstrations that many cellular proteins phase-separate to form biomolecular condensates (BMCs) that nucleate membraneless organelles (MLOs). A growing repertoire of mechanisms supporting BMC formation, composition, dynamics, and functions are becoming elucidated. BMCs are now appreciated as required for several steps of gene regulation, while their deregulation promotes pathological aggregates, such as stress granules (SGs) and insoluble irreversible plaques that are hallmarks of neurodegenerative diseases. Treatment of BMC-related diseases will greatly benefit from identification of therapeutics preventing pathological aggregates while sparing BMCs required for cellular functions. Numerous viruses that block SG assembly also utilize or engineer BMCs for their replication. While BMC formation first depends on prion-like disordered protein domains (PrLDs), metal ion-controlled RNA-binding domains (RBDs) also orchestrate their formation. Virus replication and viral genomic RNA (vRNA) packaging dynamics involving nucleocapsid (NC) proteins and their orthologs rely on Zinc (Zn) availability, while virus morphology and infectivity are negatively influenced by excess Copper (Cu). While virus infections modify physiological metal homeostasis towards an increased copper to zinc ratio (Cu/Zn), how and why they do this remains elusive.
    [Show full text]
  • How Influenza Virus Uses Host Cell Pathways During Uncoating
    cells Review How Influenza Virus Uses Host Cell Pathways during Uncoating Etori Aguiar Moreira 1 , Yohei Yamauchi 2 and Patrick Matthias 1,3,* 1 Friedrich Miescher Institute for Biomedical Research, 4058 Basel, Switzerland; [email protected] 2 Faculty of Life Sciences, School of Cellular and Molecular Medicine, University of Bristol, Bristol BS8 1TD, UK; [email protected] 3 Faculty of Sciences, University of Basel, 4031 Basel, Switzerland * Correspondence: [email protected] Abstract: Influenza is a zoonotic respiratory disease of major public health interest due to its pan- demic potential, and a threat to animals and the human population. The influenza A virus genome consists of eight single-stranded RNA segments sequestered within a protein capsid and a lipid bilayer envelope. During host cell entry, cellular cues contribute to viral conformational changes that promote critical events such as fusion with late endosomes, capsid uncoating and viral genome release into the cytosol. In this focused review, we concisely describe the virus infection cycle and highlight the recent findings of host cell pathways and cytosolic proteins that assist influenza uncoating during host cell entry. Keywords: influenza; capsid uncoating; HDAC6; ubiquitin; EPS8; TNPO1; pandemic; M1; virus– host interaction Citation: Moreira, E.A.; Yamauchi, Y.; Matthias, P. How Influenza Virus Uses Host Cell Pathways during 1. Introduction Uncoating. Cells 2021, 10, 1722. Viruses are microscopic parasites that, unable to self-replicate, subvert a host cell https://doi.org/10.3390/ for their replication and propagation. Despite their apparent simplicity, they can cause cells10071722 severe diseases and even pose pandemic threats [1–3].
    [Show full text]
  • Structural Organization of a Filamentous Influenza a Virus
    Structural organization of a filamentous influenza A virus Lesley J. Calder, Sebastian Wasilewski, John A. Berriman1, and Peter B. Rosenthal2 Division of Physical Biochemistry, MRC National Institute for Medical Research, London NW7 1AA, United Kingdom Edited* by Robert A. Lamb, Northwestern University, Evanston, IL, and approved April 27, 2010 (received for review February 26, 2010) Influenza is a lipid-enveloped, pleomorphic virus. We combine electron HA trimer in the neutral pH conformation (9), proteolytic frag- cryotomography and analysis of images of frozen-hydrated virions ments of the HA in the low pH conformation (10, 11), and the NA to determine the structural organization of filamentous influenza A tetramer (12, 13) have provided a molecular understanding of the virus. Influenza A/Udorn/72 virions are capsule-shaped or filamentous function of these proteins. particles of highly uniform diameter. We show that the matrix layer Further understanding of the virus life cycle requires 3D studies adjacent to the membrane is an ordered helix of the M1 protein and its of ultrastructure that can identify the specific molecular inter- close interaction with the surrounding envelope determines virion actions that govern virus self-assembly. In addition, ultrastructural morphology. The ribonucleoprotein particles (RNPs) that package the changes that are essential to membrane fusion and virion disas- genome segments form a tapered assembly at one end of the virus sembly during cell entry remain to be described. Electron cry- interior. The neuraminidase, which is present in smaller numbers than omicroscopy of influenza virions that are vitrified by rapid plunge- the hemagglutinin, clusters in patches and are typically present at the freezing (14–17) shows contrast from virion structures themselves end of the virion opposite to RNP attachment.
    [Show full text]
  • APICAL M2 PROTEIN IS REQUIRED for EFFICIENT INFLUENZA a VIRUS REPLICATION by Nicholas Wohlgemuth a Dissertation Submitted To
    APICAL M2 PROTEIN IS REQUIRED FOR EFFICIENT INFLUENZA A VIRUS REPLICATION by Nicholas Wohlgemuth A dissertation submitted to Johns Hopkins University in conformity with the requirements for the degree of Doctor of Philosophy Baltimore, Maryland October, 2017 © Nicholas Wohlgemuth 2017 All rights reserved ABSTRACT Influenza virus infections are a major public health burden around the world. This dissertation examines the influenza A virus M2 protein and how it can contribute to a better understanding of influenza virus biology and improve vaccination strategies. M2 is a member of the viroporin class of virus proteins characterized by their predicted ion channel activity. While traditionally studied only for their ion channel activities, viroporins frequently contain long cytoplasmic tails that play important roles in virus replication and disruption of cellular function. The currently licensed live, attenuated influenza vaccine (LAIV) contains a mutation in the M segment coding sequence of the backbone virus which confers a missense mutation (alanine to serine) in the M2 gene at amino acid position 86. Previously discounted for not showing a phenotype in immortalized cell lines, this mutation contributes to both the attenuation and temperature sensitivity phenotypes of LAIV in primary human nasal epithelial cells. Furthermore, viruses encoding serine at M2 position 86 induced greater IFN-λ responses at early times post infection. Reversing mutations such as this, and otherwise altering LAIV’s ability to replicate in vivo, could result in an improved LAIV development strategy. Influenza viruses infect at and egress from the apical plasma membrane of airway epithelial cells. Accordingly, the virus transmembrane proteins, HA, NA, and M2, are all targeted to the apical plasma membrane ii and contribute to egress.
    [Show full text]
  • XFEL Structures of the Influenza M2 Proton Channel: SPECIAL FEATURE Room Temperature Water Networks and Insights Into Proton Conduction
    XFEL structures of the influenza M2 proton channel: SPECIAL FEATURE Room temperature water networks and insights into proton conduction Jessica L. Thomastona, Rahel A. Woldeyesb, Takanori Nakane (中根 崇智)c, Ayumi Yamashitad, Tomoyuki Tanakad, Kotaro Koiwaie, Aaron S. Brewsterf, Benjamin A. Baradb, Yujie Cheng, Thomas Lemmina, Monarin Uervirojnangkoornh,i,j,k,l, Toshi Arimad, Jun Kobayashid, Tetsuya Masudad,m, Mamoru Suzukid,n, Michihiro Sugaharad, Nicholas K. Sauterf, Rie Tanakad, Osamu Nurekic, Kensuke Tonoo, Yasumasa Jotio, Eriko Nangod, So Iwatad,p, Fumiaki Yumotoe, James S. Fraserb, and William F. DeGradoa,1 aDepartment of Pharmaceutical Chemistry, University of California, San Francisco, CA 94158; bDepartment of Bioengineering and Therapeutic Sciences, University of California, San Francisco, CA 94158; cDepartment of Biological Sciences, Graduate School of Science, The University of Tokyo, Tokyo 113-0033, Japan; dSPring-8 Angstrom Compact Free Electron Laser (SACLA) Science Research Group, RIKEN SPring-8 Center, Saitama 351-0198, Japan; eStructural Biology Research Center, High Energy Accelerator Research Organization (KEK), Ibaraki 305-0801, Japan; fMolecular Biophysics and Integrated Bioimaging Division, Lawrence Berkeley National Laboratory, Berkeley, CA 94720; gSchool of Applied and Engineering Physics, Cornell University, Ithaca, NY 14853; hDepartment of Molecular and Cellular Physiology, Stanford University, Stanford, CA 94305; iHoward Hughes Medical Institute, Stanford University, Stanford, CA 94305; jDepartment of Neurology
    [Show full text]
  • Virus Entry, Assembly, Budding, and Membrane Rafts Nathalie Chazal, Denis Gerlier
    Virus Entry, Assembly, Budding, and Membrane Rafts Nathalie Chazal, Denis Gerlier To cite this version: Nathalie Chazal, Denis Gerlier. Virus Entry, Assembly, Budding, and Membrane Rafts. Microbi- ology and Molecular Biology Reviews, American Society for Microbiology, 2003, 67 (2), pp.226-237. 10.1128/MMBR.67.2.226-237.2003. hal-02147208 HAL Id: hal-02147208 https://hal.archives-ouvertes.fr/hal-02147208 Submitted on 7 Jun 2019 HAL is a multi-disciplinary open access L’archive ouverte pluridisciplinaire HAL, est archive for the deposit and dissemination of sci- destinée au dépôt et à la diffusion de documents entific research documents, whether they are pub- scientifiques de niveau recherche, publiés ou non, lished or not. The documents may come from émanant des établissements d’enseignement et de teaching and research institutions in France or recherche français ou étrangers, des laboratoires abroad, or from public or private research centers. publics ou privés. MICROBIOLOGY AND MOLECULAR BIOLOGY REVIEWS, June 2003, p. 226–237 Vol. 67, No. 2 1092-2172/03/$08.00ϩ0 DOI: 10.1128/MMBR.67.2.226–237.2003 Copyright © 2003, American Society for Microbiology. All Rights Reserved. Virus Entry, Assembly, Budding, and Membrane Rafts Nathalie Chazal1* and Denis Gerlier2 Immunologie-Virologie, EA 3038, Universite´Paul Sabatier, 31062 Toulouse,1 and Immunite´& Infections Virales, CNRS-UCBL UMR 5537, IFR Laennec, 69372 Lyon Cedex 08,2 France INTRODUCTION .......................................................................................................................................................226
    [Show full text]
  • Better Influenza Vaccines: an Industry Perspective Juine-Ruey Chen1†, Yo-Min Liu2,3†, Yung-Chieh Tseng2 and Che Ma2*
    Chen et al. Journal of Biomedical Science (2020) 27:33 https://doi.org/10.1186/s12929-020-0626-6 REVIEW Open Access Better influenza vaccines: an industry perspective Juine-Ruey Chen1†, Yo-Min Liu2,3†, Yung-Chieh Tseng2 and Che Ma2* Abstract Vaccination is the most effective measure at preventing influenza virus infections. However, current seasonal influenza vaccines are only protective against closely matched circulating strains. Even with extensive monitoring and annual reformulation our efforts remain one step behind the rapidly evolving virus, often resulting in mismatches and low vaccine effectiveness. Fortunately, many next-generation influenza vaccines are currently in development, utilizing an array of innovative techniques to shorten production time and increase the breadth of protection. This review summarizes the production methods of current vaccines, recent advances that have been made in influenza vaccine research, and highlights potential challenges that are yet to be overcome. Special emphasis is put on the potential role of glycoengineering in influenza vaccine development, and the advantages of removing the glycan shield on influenza surface antigens to increase vaccine immunogenicity. The potential for future development of these novel influenza vaccine candidates is discussed from an industry perspective. Keywords: Influenza virus, Universal vaccine, Monoglycosylated HA, Monoglycosylated split vaccine Background Recurrent influenza epidemics with pre-existing im- Seasonal influenza outbreaks cause 3 to 5 million cases
    [Show full text]
  • Vesicular Release of Ebola Virus Matrix Protein VP40
    Virology 283, 1–6 (2001) doi:10.1006/viro.2001.0860, available online at http://www.idealibrary.com on View metadata, citation and similar papers at core.ac.uk brought to you by CORE provided by Elsevier - Publisher Connector RAPID COMMUNICATION Vesicular Release of Ebola Virus Matrix Protein VP40 Joanna Timmins, Sandra Scianimanico, Guy Schoehn, and Winfried Weissenhorn1 EMBL, 6 rue Jules Horowitz, B.P. 181, 38042 Grenoble, France Received September 20, 2000; returned to author for revision October 26, 2000, accepted February 7, 2001 We have analysed the expression and cellular localisation of the matrix protein VP40 from Ebola virus. Full-length VP40 and an N-terminal truncated construct missing the first 31 residues [VP40(31–326)] both locate to the plasma membrane of 293T cells when expressed transiently, while a C-terminal truncation of residues 213 to 326 [VP40(31–212)] shows only expression in the cytoplasm, when analysed by indirect immunofluorescence and plasma membrane preparations. In addition, we find that full-length VP40 [VP40(1–326)] and VP40(31–326) are both released into the cell culture supernatant and float up in sucrose gradients. The efficiency of their release, however, is dependent on the presence of the N-terminal 31 residues. VP40 that is released into the supernatant is resistant to trypsin digestion, a finding that is consistent with the formation of viruslike particles detected by electron microscopy. Together, these results provide strong evidence that Ebola virus VP40 is sufficient for virus assembly and budding from the plasma membrane. © 2001 Academic Press INTRODUCTION to liposomes (12). Although it has been shown that the VSV matrix protein is released from cells in the form of Ebola virus and Marburg virus (Filoviridae) are non- lipid vesicles (13, 14), the efficiency of assembly and segmented negative-strand RNA viruses (Mononegavi- particle release depends on interactions with cellular rales) that cause severe hemorrhagic fever in humans proteins mediated by a conserved WW domain binding (1–3).
    [Show full text]
  • Retained Scfv a Master's Thesis Prese
    Reduction in Viral Surface Hemagglutinin Incorporation by Co-expressing HA-targeting ER- retained scFv A Master’s Thesis Presented to The Faculty of the Graduate School of Arts and Sciences Brandeis University Department of Biochemistry Dr. Tijana Ivanovic, Advisor In Partial Fulfillment of the Requirements for the Degree Master of Science by Zhenyu Li May 2020 Copyright by Zhenyu Li 2020 Acknowledgement I would like to thank Dr. Ivanovic for giving me this wonderful opportunity to work on this project. I would like to thank Dr. Tian Li and Erin Deans for their help for the past two years for my experiments and writing. I want to thank Ellen Nguyen for her virus infectivity data. Lastly, I want to thank the Ivanovic lab for all the support and love. iii ABSTRACT Reduction in Viral Surface Hemagglutinin Incorporation by Co-expressing HA-targeting ER- retained scFv A thesis presented to the Faculty of the Graduate School of Arts and Sciences of Brandeis University Waltham, Massachusetts By Zhenyu Li Membrane fusion is a common process for all enveloped viruses to penetrate host cells. Influenza viral surface glycoprotein, hemagglutinin (HA) mediates viral membrane fusion with the endosomal membrane. Viral surface is densely covered by hundreds of HAs, and about a hundred of them reside at the viral and endosomal contact interface (contact patch). Within the contact patch, three to five adjacent HAs need to insert into the endosomal membrane and fold back cooperatively to induce membrane fusion. However, about half of the HAs fail to insert into the target membrane and instead become inactivated.
    [Show full text]
  • Viroporins: Structure, Function and Potential As Antiviral Targets
    This is a repository copy of Viroporins: Structure, function and potential as antiviral targets. White Rose Research Online URL for this paper: http://eprints.whiterose.ac.uk/88837/ Version: Accepted Version Article: Scott, C and Griffin, S orcid.org/0000-0002-7233-5243 (2015) Viroporins: Structure, function and potential as antiviral targets. Journal of General Virology, 96 (8). pp. 2000-2027. ISSN 0022-1317 https://doi.org/10.1099/vir.0.000201 © 2015 The Authors. Published by the Microbiology Society. This is an author produced version of a paper published in Journal of General Virology. Uploaded in accordance with the publisher's self-archiving policy. Reuse Unless indicated otherwise, fulltext items are protected by copyright with all rights reserved. The copyright exception in section 29 of the Copyright, Designs and Patents Act 1988 allows the making of a single copy solely for the purpose of non-commercial research or private study within the limits of fair dealing. The publisher or other rights-holder may allow further reproduction and re-use of this version - refer to the White Rose Research Online record for this item. Where records identify the publisher as the copyright holder, users can verify any specific terms of use on the publisher’s website. Takedown If you consider content in White Rose Research Online to be in breach of UK law, please notify us by emailing [email protected] including the URL of the record and the reason for the withdrawal request. [email protected] https://eprints.whiterose.ac.uk/ Journal of General Virology Viroporins: structure, function and potential as antiviral targets --Manuscript Draft-- Manuscript Number: VIR-D-15-00200R1 Full Title: Viroporins: structure, function and potential as antiviral targets Article Type: Review Section/Category: High Priority Review Corresponding Author: Stephen D.
    [Show full text]
  • Insights Into the Roles of Cyclophilin a During Influenza Virus Infection
    Viruses 2013, 5, 182-191; doi:10.3390/v5010182 OPEN ACCESS viruses ISSN 1999-4915 www.mdpi.com/journal/viruses Review Insights into the Roles of Cyclophilin A During Influenza Virus Infection Xiaoling Liu, Zhendong Zhao and Wenjun Liu * Center for Molecular Virology, Key Laboratory of Pathogenic Microbiology and Immunology, Institute of Microbiology, Chinese Academy of Sciences, Beijing 100101, China; E-Mails: [email protected] (X.L.), [email protected] (Z.Z.) * Author to whom correspondence should be addressed; E-Mail: [email protected]; Tel.: +86-10-64807497; Fax: +86-10-64807503. Received: 22 November 2012; in revised form: 22 December 2012 / Accepted: 9 January 2013 / Published: 15 January 2013 Abstract: Cyclophilin A (CypA) is the main member of the immunophilin superfamily that has peptidyl-prolyl cis-trans isomerase activity. CypA participates in protein folding, cell signaling, inflammation and tumorigenesis. Further, CypA plays critical roles in the replication of several viruses. Upon influenza virus infection, CypA inhibits viral replication by interacting with the M1 protein. In addition, CypA is incorporated into the influenza virus virions. Finally, Cyclosporin A (CsA), the main inhibitor of CypA, inhibits influenza virus replication through CypA-dependent and -independent pathways. This review briefly summarizes recent advances in understanding the roles of CypA during influenza virus infection. Keywords: influenza virus; Cyclophilin A; Cyclosporin A; virus-host interaction 1. Introduction Influenza virus is an enveloped negative-sense RNA virus that causes major public health problems worldwide. There are eight RNA segments in the influenza A virus encoding 14 viral proteins: the polymerase proteins (PB1, PB2, PA) [1,2], nucleocapsid protein (NP), hemagglutinin (HA), neuraminidase (NA), matrix proteins (M1 and M2), nonstructural proteins (NS1 and NS2) and the recently described PB1-F2, PB1 N40, PA-X and M42 proteins [1–4].
    [Show full text]
  • Intracellular Redox-Modulated Pathways As Targets for Effective Approaches in the Treatment of Viral Infection
    International Journal of Molecular Sciences Review Intracellular Redox-Modulated Pathways as Targets for Effective Approaches in the Treatment of Viral Infection Alessandra Fraternale 1,* , Carolina Zara 1, Marta De Angelis 2 , Lucia Nencioni 2 , Anna Teresa Palamara 2,3 , Michele Retini 1 , Tomas Di Mambro 1, Mauro Magnani 1 and Rita Crinelli 1 1 Department of Biomolecular Sciences, University of Urbino Carlo Bo, Via Saffi 2, 61029 Urbino (PU), Italy; [email protected] (C.Z.); [email protected] (M.R.); [email protected] (T.D.M.); [email protected] (M.M.); [email protected] (R.C.) 2 Department of Public Health and Infectious Diseases, Laboratory Affiliated to Istituto Pasteur Italia-Fondazione Cenci Bolognetti, Sapienza University of Rome, Piazzale Aldo Moro 5, 00185 Rome, Italy; [email protected] (M.D.A.); [email protected] (L.N.); [email protected] (A.T.P.) 3 IRCCS San Raffaele Pisana, Department of Human Sciences and Promotion of the Quality of Life, San Raffaele Roma Open University, Via di Val Cannuta 247, 00166 Rome, Italy * Correspondence: [email protected] Abstract: Host-directed therapy using drugs that target cellular pathways required for virus lifecycle or its clearance might represent an effective approach for treating infectious diseases. Changes in redox homeostasis, including intracellular glutathione (GSH) depletion, are one of the key events that favor virus replication and contribute to the pathogenesis of virus-induced disease. Redox Citation: Fraternale, A.; Zara, C.; homeostasis has an important role in maintaining an appropriate Th1/Th2 balance, which is necessary De Angelis, M.; Nencioni, L.; Palamara, A.T.; Retini, M.; Di to mount an effective immune response against viral infection and to avoid excessive inflammatory Mambro, T.; Magnani, M.; Crinelli, R.
    [Show full text]